09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
3530 HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601<br />
MKP Broj objave europske Naziv izuma<br />
prijave patenta<br />
(51) (97) (54)<br />
C07D 498/04 (2006.01) EP 2<strong>09</strong>4713 * EPOTHILONE ANALOGUES MODIFIED AT POSITIONS C12-C13 AS ANTICANCER DRUGS<br />
C07D 498/08 (2006.01) EP 2086982 * HCV NS3 PROTEASE INHIBITORS<br />
C07D 498/18 (2006.01) EP 2086982 * HCV NS3 PROTEASE INHIBITORS<br />
C07D 513/04 (2006.01) EP 2<strong>09</strong>4671 * HETEROBICYCLIC METALLOPROTEASE INHIBITORS<br />
C07D 513/04 (2006.01) EP 2<strong>09</strong>4690 * 2-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS<br />
C07F 5/02 (2006.01) EP 2<strong>09</strong>8529 * PH-SENSITIVE FLUORESCENT PROBE<br />
C07F 5/02 (2006.01) EP 2<strong>09</strong>9790 * PROCESS FOR PREPARING NEBIVOLOL<br />
C07F 7/02 (2006.01) EP 2074135 * SILICON DERIVATIVES FOR PET IMAGING<br />
C07F 9/<strong>09</strong> (2006.01) EP 2<strong>09</strong>9768 * AGONISTS OF THE SPHINGOSINE-1-PHOSPHATE RECEPTOR<br />
C07F 9/30 (2006.01) EP 2<strong>09</strong>4720 * SELECTIVE INHIBITORS OF NEUROTENSIN DEGRADING ENZYMES<br />
C07H 15/12 (2006.01) EP 2<strong>09</strong>6116 * SODIUM SALT OF DISACCHARIDE COMPOUND, METHOD FOR PRODUCING THE SAME,<br />
AND USE OF THE SAME<br />
C07H 21/00 (2006.01) EP 2<strong>09</strong>9825 * RECOMBINANT ANTIBODIES AGAINST HEPATITIS C VIRUS AND METHODS OF<br />
OBTAINING AND USING SAME<br />
C07H 21/02 (2006.01) EP 2089412 * SUPPRESSION OF MITOCHONDRIAL OXIDATIVE STRESS<br />
C07H 21/02 (2006.01) EP 2<strong>09</strong>7435 * THERAPEUTIC TREATMENTS BASED ON ADMINISTRATION OF SMALL RNA FRAGMENTS<br />
C07H 21/04 (2006.01) EP 2087002 * COMPOSITIONS AND METHODS FOR BINDING SPHINGOSINE-1-PHOSPHATE<br />
C07H 21/04 (2006.01) EP 2<strong>09</strong>4726 * COMPOSITIONS AND METHODS RELATED TO TOLL-LIKE RECEPTOR-3<br />
C07H 21/04 (2006.01) EP 2<strong>09</strong>7539 * POLYMORPHISMS IN THE UROCORTIN 3 GENE AND THEIR ASSOCIATIONS WITH<br />
MARBLING AND SUBCUTANEOUS FAT DEPTH IN BEEF CATTLE<br />
C07J 53/00 (2006.01) EP 2019114 Process for the preparation of Drospirenone<br />
C07K 1/00 (2006.01) EP 2089428 * CRYSTALLINE ANTI-HTNFALPHA ANTIBODIES<br />
C07K 1/13 (2006.01) EP 2074135 * SILICON DERIVATIVES FOR PET IMAGING<br />
C07K 14/07 (2006.01) EP 2<strong>09</strong>7517 * MODIFIED VACCINIA VIRUS STRAINS FOR USE IN DIAGNOSTIC AND THERAPEUTIC<br />
METHODS<br />
C07K 14/245 (2006.01) EP 2<strong>09</strong>7529 * METHODS OF SELECTING AND PRODUCING MODIFIED TOXINS, CONJUGATES<br />
CONTAINING MODIFIED TOXINS AND USES THEREOF<br />
C07K 14/25 (2006.01) EP 2<strong>09</strong>7529 * METHODS OF SELECTING AND PRODUCING MODIFIED TOXINS, CONJUGATES<br />
CONTAINING MODIFIED TOXINS AND USES THEREOF<br />
C07K 14/315 (2006.01) EP 2<strong>09</strong>7100 * PEPTIDES PROTECTIVE AGAINST S. PNEUMONIAE AND COMPOSITIONS, METHODS<br />
AND USES RELATING THERETO<br />
C07K 14/435 (2006.01) EP 1985304 Novel compounds and their effects on feeding behaviour<br />
C07K 14/47 (2006.01) EP 2<strong>09</strong>2069 * MODIFIED SOLUBLE FGF RECEPTOR FC FUSIONS WITH IMPROVED BIOLOGICAL<br />
ACTIVITY<br />
C07K 14/475 (2006.01) EP 2<strong>09</strong>7529 * METHODS OF SELECTING AND PRODUCING MODIFIED TOXINS, CONJUGATES<br />
CONTAINING MODIFIED TOXINS AND USES THEREOF<br />
C07K 14/52 (2006.01) EP 2<strong>09</strong>7529 * METHODS OF SELECTING AND PRODUCING MODIFIED TOXINS, CONJUGATES<br />
CONTAINING MODIFIED TOXINS AND USES THEREOF<br />
C07K 14/535 (2006.01) EP 2<strong>09</strong>9495 * CONJUGATES OF A G-CSF MOIETY AND A POLYMER<br />
C07K 14/705 (2006.01) EP 2<strong>09</strong>4726 * COMPOSITIONS AND METHODS RELATED TO TOLL-LIKE RECEPTOR-3<br />
C07K 14/705 (2006.01) EP 2<strong>09</strong>4732 * DR6 ANTIBODIES INHIBITING THE BINDING OF DR6 TO APP, AND USES THEREOF IN<br />
TREATING NEUROLOGICAL DISORDERS<br />
C07K 14/705 (2006.01) EP 2<strong>09</strong>7444 * TRANSGENIC ANIMAL WITH ENHANCED IMMUNE RESPONSE AND METHOD FOR THE<br />
PREPARATION THEREOF<br />
C07K 14/71 (2006.01) EP 2<strong>09</strong>2069 * MODIFIED SOLUBLE FGF RECEPTOR FC FUSIONS WITH IMPROVED BIOLOGICAL<br />
ACTIVITY<br />
C07K 14/71 (2006.01) EP 2<strong>09</strong>9920 * TRANSGENIC MICE EXPRESSING HUMANIZED VEGF<br />
C07K 14/82 (2006.01) EP 2<strong>09</strong>8595 * HLA-A*1101-RESTRICTED WT1 PEPTIDE AND PHARMACEUTICAL COMPOSITION<br />
COMPRISING THE SAME<br />
C07K 16/00 (2006.01) EP 2087002 * COMPOSITIONS AND METHODS FOR BINDING SPHINGOSINE-1-PHOSPHATE<br />
C07K 16/00 (2006.01) EP 2088997 * LIQUID ANTI-RABIES ANTIBODY FORMULATIONS<br />
C07K 16/00 (2006.01) EP 2089428 * CRYSTALLINE ANTI-HTNFALPHA ANTIBODIES<br />
C07K 16/00 (2006.01) EP 2<strong>09</strong>4282 * ANTI-TSG101 ANTIBODIES AND THEIR USES FOR TREATMENT OF VIRAL INFECTIONS<br />
C07K 16/00 (2006.01) EP 2<strong>09</strong>4726 * COMPOSITIONS AND METHODS RELATED TO TOLL-LIKE RECEPTOR-3<br />
C07K 16/00 (2006.01) EP 2<strong>09</strong>7529 * METHODS OF SELECTING AND PRODUCING MODIFIED TOXINS, CONJUGATES<br />
CONTAINING MODIFIED TOXINS AND USES THEREOF<br />
C07K 16/00 (2006.01) EP 2<strong>09</strong>7747 * ANALYTICAL METHOD FOR ANALYZING C-TERMINUS TRUNCATION<br />
C07K 16/00 (2006.01) EP 2<strong>09</strong>9824 * ENTEROCOCCUS FAECALIS AND/OR ENTEROCOCCUS FAECIUM ANTIGEN<br />
C07K 16/08 (2006.01) EP 2<strong>09</strong>9825 * RECOMBINANT ANTIBODIES AGAINST HEPATITIS C VIRUS AND METHODS OF<br />
OBTAINING AND USING SAME<br />
C07K 16/18 (2006.01) EP 2087002 * COMPOSITIONS AND METHODS FOR BINDING SPHINGOSINE-1-PHOSPHATE<br />
C07K 16/18 (2006.01) EP 2087103 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />
C07K 16/18 (2006.01) EP 2089514 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />
C07K 16/18 (2006.01) EP 2<strong>09</strong>4729 * ABETA ANTIBODY PARENTERAL FORMULATION<br />
C07K 16/18 (2006.01) EP 2<strong>09</strong>6122 * ANTI-HUMAN DLK-1 ANTIBODY SHOWING ANTI-TUMOR ACTIVITY IN VIVO<br />
ISSN 1331-2030